Please join us on May 23 from 3-4 pm Eastern (2-3 pm Central, 12-1 pm Pacific) for an HCL Clinical Trials webinar, part of a new series exploring clinical trials in hairy cell leukemia. Through this series, we aim to inform our patient network about current trials and empower them with options.
On May 23, Dr. David Hermel from the Scripps Clinic will discuss their trial using low-dose Vemurafenib plus Rituximab. There will be time for Q&A.
You can learn more about HCL clinical trials in HCL through the HCLF website. >>